: .
- . (SPF), 330 . . , 77,1 . . .
2486 COVID-19, 310 . – 126 . .
2828,6 100 000 . . 19,5 19,4%.
Novavax
692 092 . 53,5 (.. 79,4% ) , 52,2 (.. 77,5% ) .
Novavax, . Nuvaxovid. Janssen, 55 , Novavax , , Pfizer Moderna.
, , , .
, Novavax .
Novavax 21 . MA . Nuvaxovid – COVID-19, .
, , , . . , , , – .
600 000 covid
- , , , . 65 . , 600 000 covid, .
, covid, , , . .
, : , . , .
, . , , . 20%, . 400 000 5 11 , COVID-19.
, , , .
:
-
0 |
|
0 |
|
|